Genpact Announces Renewed Partnership With Ferring Pharmaceuticals
Genpact Announces Renewed Partnership With Ferring Pharmaceuticals
Under the agreement, Genpact will continue to streamline workflows, optimize resource allocation, and improve the accuracy and speed of financial transactions. In collaboration with technology partners like Xelix and Blackline, Genpact will automate key processes, such as invoice management and procurement workflows, while establishing robust data analytics capabilities for real-time financial insights. These enhancements aim to deliver significant operational savings and enable Ferring to adapt swiftly to evolving customer and patient needs.Renewed multi-year partnership to support Ferring Pharmaceuticals' operations in response to rapid business growth
重新签订的多年合作伙伴关系将支持费林制药应对快速的业务增长
NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that has operating subsidiaries in more than 50 countries and markets its medicines in over 100 countries. The renewed multi-year agreement will continue the transformation of Ferring's finance, accounting, and procurement operations with advanced technologies, including AI.
纽约，2024年11月21日 /美通社/ -- 简伯特（纽交所：G），一家全球专业服务和解决方案公司，致力于提供塑造未来的成果，今天宣布与费林制药的合作伙伴关系延续。费林制药是一家以研究为驱动的生物制药公司，在50多个国家设有运营子公司，产品在100多个国家市场销售。续签的多年协议将继续利用爱文思控股，包括人工智能等先进科技，转型费林的财务、会计和采购运营。
"To drive growth in a complex and competitive environment, pharmaceutical companies need modern, scalable and efficient solutions," said Sanjiv Tandon, Global Head of Life Sciences and Healthcare, Genpact. "Our ongoing partnership with Ferring Pharmaceuticals leverages our industry expertise and a shared vision to harness advanced technologies, setting a new standard for innovation and enabling Ferring to meet evolving demands with speed and accuracy."
费林制药全球生命科学与医疗首席负责人Sanjiv Tandon表示：“在复杂而竞争激烈的环境中推动增长，制药公司需要现代、可扩展和高效的解决方案。我们的持续合作伙伴关系利用我们在行业中的专业知识和共同愿景，结合先进科技，为创新设定了新的标准，使费林能迅速准确地应对不断变化的需求。”
Under the agreement, Genpact will continue to streamline workflows, optimize resource allocation, and improve the accuracy and speed of financial transactions. In collaboration with technology partners like Xelix and Blackline, Genpact will automate key processes, such as invoice management and procurement workflows, while establishing robust data analytics capabilities for real-time financial insights. These enhancements aim to deliver significant operational savings and enable Ferring to adapt swiftly to evolving customer and patient needs.
根据协议，简伯特将继续精简工作流程，优化资源配置，提高财务交易的准确性和速度。与Xelix和blackline等科技合作伙伴合作，简伯特将自动化关键流程，如发票管理和采购工作流程，同时建立强大的数据分析能力，以实现实时财务洞察。这些提升旨在提供显著的运营节约，使费林能够迅速适应不断变化的客户和患者需求。
"Our partnership with Genpact spans over 40 digital transformation projects, with a strong focus on AI applications," said Dominic Moorhead, Chief Financial Officer, Ferring Pharmaceuticals. "By standardizing processes and leveraging advanced technologies, like AI, we're enhancing accuracy, real-time insights, and overall efficiency to support our purpose of building families and helping people live better lives."
费林制药首席财务官Dominic Moorhead表示：“我们与简伯特的合作涵盖了40多个数字化转型项目，重点关注人工智能应用。通过标准化流程和利用先进科技，如人工智能，我们提高了准确性、实时洞察力以及整体效率，以支持我们建立家庭和帮助人们过上更好生活的目标。”
This collaboration underscores Ferring Pharmaceuticals' commitment to innovation, enabling the company to thrive and deliver its range of innovative treatments to change the lives of people and families around the world.
此次合作强调了费林药业对创新的承诺，使公司能够蓬勃发展并提供其创新药品的区间，改变全球人民和家庭的生活。
To learn more about Genpact's solutions and services for Healthcare and Life Sciences industries, click here.
要了解简伯特在医疗和生命科学行业的解决方案和服务，请点击这里。
About Genpact
了解我们的网站genpact.com以及LinkedIn,X,YouTube和Facebook。
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.
简伯特（NYSE：G）是一家全球性的专业服务和解决方案公司，致力于塑造未来。我们拥有30多个国家的125,000多名员工，他们被我们内在的好奇心、创业敏捷性和创造持久价值的渴望所驱动。在我们的目标——不断追求一个更适合人类生活的世界的推动下，我们为包括《财富》全球500强在内的顶尖企业提供服务和转型，秉持着我们在业务和行业方面的深度认知、数字运营服务以及数据、技术和人工智能的专业知识。
Get to know us at genpact.com and on LinkedIn, X, YouTube, and Facebook.
了解我们，请访问 genpact.com 关于CSO的信息：CSO是为企业安全决策者和用户服务的，为他们提供所需的关键信息，以保持在不断发展的威胁前沿并防御犯罪网络攻击。由于我们的详尽内容涵盖了所有安全领域，从风险管理到网络防御再到防诈骗和数据丢失预防，因此CSO为IT安全专业人员提供了无与伦比的深度和洞察力来支持关键决策和投资。LinkedIn, X, YouTube，和 Facebook.
MEDIA CONTACT:
媒体联系人：
Sue Martenson
Genpact Media Relations
+1 978-905-9582
[email protected]
Sue Martenson
简伯特媒体关系
+1 978-905-9582
[email protected]
SOURCE Genpact Ltd.
Genpact Ltd. 的消息来源。